Remimazolam's effect on memory in glioma patients
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how a sedative called remimazolam affects memory and brain activity. It compares people with healthy brains to people who have a glioma (brain tumor) to understand how the tumor may change these effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your first language is Chinese and you are right-handed.
- Either you have a healthy brain (no tumors) and need a non-brain surgery, or you have a glioma (a brain tumor) on one side that requires surgery and anesthesia.
- You do not have certain medical conditions like a history of drug abuse, severe mental illness, or allergies to the study medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the anesthesia medicine remimazolam can improve recovery and longer-term outcomes after surgery for early-stage bladder cancer. If you are having a bladder tumor procedure through the urethra, this study may help doctors understand whether this anesthesia choice matters for prognosis.
This study tests whether remimazolam, a sedative medication, affects thinking and memory after heart surgery with a heart-lung machine. Researchers want to know if this drug is safer for the brain during major heart surgery in older adults.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study tests a medicine called remimazolam to see if it reduces confusion and agitation (emergence delirium) when children wake up from brain surgery. It may help your child have a smoother recovery.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This trial tests if a sedative called remimazolam can reduce confusion or delirium in older adults after laparoscopic stomach surgery. If you are at least 65 years old and scheduled for this surgery, you may be eligible.
Hear when a new Remimazolam Mild Sedation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.